Hochschulschrift
Genetic polymorphisms in phase-II-metabolizing enzymes and susceptibility to colorectal cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
V, 126 Bl.
- Language
-
Englisch
- Notes
-
Ill., graph. Darst.
Heidelberg, Univ., Diss., 2006
- Keyword
-
Krebs
Onkologie
- Creator
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
12.06.2002, 11:21 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Other Objects (12)
Toxicogenetic analysis of Δ9-THC-metabolizing enzymes
Genetic polymorphisms and gene expression of one-carbon metabolizing enzymes and their relation to breast cancer
Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study
Genetic polymorphisms in XRCC1 genes and colorectal cancer susceptibility
Association between polymorphisms of TAS2R16 and susceptibility to colorectal cancer
Investigation of c-di-GMP metabolizing enzymes from Streptomyces ghanaensis ATCC14672
Expression of gemcitabine metabolizing enzymes in different pancreatic cancer model systems
Development of capillary electrophoresis based assays for nucleoside and nucleotide metabolizing enzymes
Inhibition of matrix-metabolizing enzymes by dissociated glucocorticoids in rat mesangial cells
Development of capillary electrophoresis based assays for nucleoside and nucleotide metabolizing enzymes
Molecular determinants underlying substrate promiscuity and polymorphism in drug-metabolizing CYP enzymes
Xenobiotic metabolizing enzyme gene polymorphisms predict response to lung volume reduction surgery
Toxicogenetic analysis of Δ9-THC-metabolizing enzymes
Genetic polymorphisms and gene expression of one-carbon metabolizing enzymes and their relation to breast cancer
Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study
Genetic polymorphisms in XRCC1 genes and colorectal cancer susceptibility
Association between polymorphisms of TAS2R16 and susceptibility to colorectal cancer
Investigation of c-di-GMP metabolizing enzymes from Streptomyces ghanaensis ATCC14672
Expression of gemcitabine metabolizing enzymes in different pancreatic cancer model systems
Development of capillary electrophoresis based assays for nucleoside and nucleotide metabolizing enzymes
Inhibition of matrix-metabolizing enzymes by dissociated glucocorticoids in rat mesangial cells
Development of capillary electrophoresis based assays for nucleoside and nucleotide metabolizing enzymes
Molecular determinants underlying substrate promiscuity and polymorphism in drug-metabolizing CYP enzymes
Xenobiotic metabolizing enzyme gene polymorphisms predict response to lung volume reduction surgery
Toxicogenetic analysis of Δ9-THC-metabolizing enzymes
Genetic polymorphisms and gene expression of one-carbon metabolizing enzymes and their relation to breast cancer
Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study
Genetic polymorphisms in XRCC1 genes and colorectal cancer susceptibility
Association between polymorphisms of TAS2R16 and susceptibility to colorectal cancer
Investigation of c-di-GMP metabolizing enzymes from Streptomyces ghanaensis ATCC14672
Expression of gemcitabine metabolizing enzymes in different pancreatic cancer model systems
Development of capillary electrophoresis based assays for nucleoside and nucleotide metabolizing enzymes
Inhibition of matrix-metabolizing enzymes by dissociated glucocorticoids in rat mesangial cells
Development of capillary electrophoresis based assays for nucleoside and nucleotide metabolizing enzymes
Molecular determinants underlying substrate promiscuity and polymorphism in drug-metabolizing CYP enzymes